Pia Burman
21 – 30 of 60
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Reference intervals of salivary cortisol and cortisone and their diagnostic accuracy in Cushing's syndrome
(
- Contribution to journal › Article
-
Mark
Temozolomide therapy for aggressive pituitary tumours – current understanding and future perspectives
(
- Contribution to journal › Scientific review
-
Mark
Early versus late initiation of GH replacement in adult-onset hypopituitarism
(
- Contribution to journal › Article
- 2019
-
Mark
Pituitary Metastases : A Nationwide Study on Current Characteristics with Special Reference to Breast Cancer
(
- Contribution to journal › Article
-
Mark
The incidence of Cushing’s disease : a nationwide Swedish study
(
- Contribution to journal › Article
-
Mark
Change in baseline characteristics over 20 years of adults with growth hormone (GH) deficiency on GH replacement therapy
(
- Contribution to journal › Article
-
Mark
Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study
(
- Contribution to journal › Article
- 2018
-
Mark
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
(
- Contribution to journal › Article
-
Mark
Relative risks of contributing factors to morbidity and mortality in adults with craniopharyngioma on growth hormone replacement
(
- Contribution to journal › Article
-
Mark
Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide
(
- Contribution to journal › Letter